Agreements reached under this partnership
Business alliance- 1
PeptiDream provides MSD with peptide candidate compounds identified using PDPS® technology for targets selected by MSD.
- 2
MSD holds exclusive rights to the relevant peptide candidate compounds and is responsible for all development of PCC products generated through this collaboration.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
This has already been incorporated into the earnings forecast for the fiscal year ending December 2026, and there is no change to the earnings forecast.
| Item | Details |
|---|---|
| Name of alliance partner | MSD（Merck & Co., Inc.） |
| Alliance partner's business activities | The business relating to peptide candidate compounds against targets selected by MSD, and the development of PCC products generated through this collaboration |
| Alliance partner's location | Rahway, New Jersey, USA (Rahway, NJ, USA) |
| Type of alliance | Business alliance |
| Details of the alliance | PeptiDream provides MSD with peptide candidate compounds identified using PDPS® technology for targets selected by MSD., MSD holds exclusive rights to the relevant peptide candidate compounds and is responsible for all development of PCC products generated through this collaboration. |
| Impact on Business Performance | This has already been incorporated into the earnings forecast for the fiscal year ending December 2026, and there is no change to the earnings forecast. |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The candidate compound under development achieved a milestone. The company considers this an accomplishment demonstrating that the development activities of both companies are progressing smoothly.